Abstract Objective To study the relationship between Ureaplasma urealyticum (UU) infection in the lower respiratory tract and the incidence of bronchopulmonary dysplasia (BPD) in very low birth weight (VLBW) infants with respiratory distress syndrome (RDS). Methods Seventy-three VLBW infants diagnosed with neonatal RDS, who had received at least one dose of pulmonary surfactant, as well as mechanical ventilation, and were hospitalized for over 28 days, were recruited. Endotracheal aspirates were obtained from the lower respiratory tract and examined by real-time PCR to detect UU DNA. The infants were divided into UU infection and non-UU infection groups according to examination results. Clinical characteristics and the incidence of BPD were compared between the two groups. Results Compared with the non-UU infection group, the UU infection group had a higher rate of maternal vaginal delivery, higher incidence of recurrent nosocomial pulmonary infection and premature rupture of membranes (PROM), and longer durations of PROM, oxygen supplementation, and hospital stay; in addition, the UU infection group had higher plasma IgM level, leukocyte count, and neutrophil count within 3 hours after birth. Among 73 VLBW infants, 45 developed BPD; the incidence of BPD in the UU infection group was 90% (19/21), versus 50% (26/52) in the non-UU infection group (PConclusions UU infection in the lower respiratory tract increases the incidence of BPD in VLBW infants with RDS.
CHEN You,MA Li-Ya,HUANG Yan et al. Association of Ureaplasma urealyticum infection with bronchopulmonary dysplasia in very low birth weight infants with respiratory distress syndrome[J]. CJCP, 2014, 16(5): 469-472.
CHEN You,MA Li-Ya,HUANG Yan et al. Association of Ureaplasma urealyticum infection with bronchopulmonary dysplasia in very low birth weight infants with respiratory distress syndrome[J]. CJCP, 2014, 16(5): 469-472.
Sanchez-Solis M, Garcia-Marcos L, Bosch-Gimenez V, et al. Lung function among infants born preterm, with or without bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 2012, 47(7): 674-681.
Schelonka RL, Waites KB. Ureaplasma infection and neonatal lung disease. Semin Perinatol[J]. 2007, 31(1): 2-9.
[5]
Tae-Jung Sung, MD. Ureaplasma infections in pre-term infants: Recent information regarding the role of Ureaplasma species as neonatal pathogens[J]. Korean J Pediatr, 2010, 53(12): 989-993.
Viscardi RM, Hashmi N, Gross GW, et al. Incidence of invasive Ureaplasma in VLBW infants: relationship to severe intraventricular hemorrhage[J]. J Perinatol, 2008, 28(11): 759-765.
[10]
Marconi C, de Andrade Ramos BR, Peracoli JC, et al. Amniotic fluid interleukin-1 beta and interleukin-6, but not interleukin-8 correlate with microbial invasion of the amniotic cavity in preterm labor[J]. Am J Reprod Immunol, 2011, 65(6): 549-556.
[11]
Vigneswaran R. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy[J]. J Paediatr Child Health, 2000, 36(4): 293-296.
[12]
Harada K, Tanaka H, Komori S, et al. Vaginal infection with Ureaplasma urealyticum accounts for preterm delivery via induction of inflammatory responses [J]. Microbiol Immunol, 2008, 52(6): 297-304.
[13]
Payne MS, Goss KC, Connett GJ, et al. A quantitative analysis of Ureaplasma urealyticum and Ureaplasma parvum compared with host immune response in preterm neonates at risk of developing bronchopulmonary dysplasia[J]. J Clin Microbiol, 2012, 50(3): 909-914.
[14]
Schelonka RL, Katz B, Waites KB, et al. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques[J]. Pediatr Infect Dis J, 2005, 24(12): 1033-1039.
